Table 1.

Summary of Publications Reporting the Impact and Effectiveness of Quadrivalent Human Papillomavirus Vaccination Programs in 9 Countries

Country (No. of Included Publications) and HPV Vaccination Program	Publications (No.) per Endpointa
	Genital Warts	HPV Infection	Cervical Cytological Abnormalities	Cervical Histological Abnormalities
Australia (18 publications)	10	3	5	5
Since April 2007: ongoing publicly funded school-based national program, girls aged 12–13 y Up to December 2009: school-based catch-up for females aged 12–17 y and community-based catch-up for women aged 18–26 y Since February 2013: ongoing school-based national program for boys aged 12–13 y, with catch-up 14–15 y in 2013–2014b	Fairley 2009 [A29] Donovan 2011 [A28] Read 2011 [A37] Ali 2013 [A23, A24] Liu 2014 [A34] Harrison 2014 [A31] Chow 2015 [A27] Smith 2015 [A39], 2016 [A43]	Tabrizi 2012 [A4], 2014 [A5] Chow 2015 [A8]	Brotherton 2011 [A53] Gertig 2013 [A46] Crowe 2014 [A45] Brotherton 2015 [A44, A54]	Brotherton 2011 [A53] Gertig 2013 [A46] Crowe 2014 [A45] Brotherton 2015 [A44, A54]
Belgium (2 publications)	1	1	…	…
November 2007: females 12–15 y reimbursed End of 2008: reimbursement extended to age 18 y Since 2010/2011: school-based, girls aged 12–13 y	Dominiak-Felden 2015 [A17]	Merckx 2014 [A14]
Canada (3 publications)	1	…	2	1
Since 2007–2009: school-based, targeting girls grades 4–8 in all provinces/territories	Smith 2015 [A20]		Mahmud 2014 [A47] Smith 2015 [A20]	Ogilvie 2015 [A58]
Denmark (8 publications)	5	…	2	3
2006: licensed October 2008: 1st catch-up, females aged 13–15 y, free Since 2009: females aged 12 y, free August 2012: 2nd catch-up, females aged ≤27 y old	Baandrup 2013 [A25] Blomberg 2013 [A21] Sando 2014 [A38] Blomberg 2015 [A16] Bollerup 2016 [A42]		Baldur-Felskov 2014 [A48, A51]	Baldur-Felskov 2014 [A48, A51], 2015 [A52]
France (1 publication)	1	…	…	…
Initially: recommended for females ≥14 y old with no prior sexual intercourse or within 1st year following sexual debut Since September 2012: recommended in females aged 11–14 y, with catch-up for females 15–19 y	Judlin 2015 [A32]
Germany (2 publications)	1	1	…	…
Since 2007: females aged 13–17, free	Mikolajczyk 2013 [A35]	Delere 2014 [A2]
New Zealand (2 publications)	2	…	…	…
September 2008: vaccine available February 2009: school program for females aged 12–13 y, with catch-up until 2010 for females <20 y	Oliphant 2011 [A36] Wilson 2014 [A40]
Sweden (5 publications)	3	1	…	1
2006–2011: public subsidy for on-demand vaccination, females aged 13–17 y Since 2012: organized, publicly funded school-based vaccination of females aged 10–12 y with catch-up for females 13–18 y	Leval 2012 [A33], 2013 [A19] Herweijer 2014 [A18]	Soderlund-Strand 2014 [A13]		Herweijer 2016 [A50]
United States (17 publications)	4	9	…	4
Since 2006: US Advisory Committee on Immunization Practices recommended routine vaccination for females aged ≥11 y	Bauer 2012 [A26] Swedish 2012 [A22] Flagg 2013 [A30] Nsouli-Maktabi 2013 [A41]	Cummings 2012 [A1] Kahn 2012 [A11] Powell 2012 [A6]c Schlecht 2012 [A3] Markowitz 2013 [A12] Wilson 2014 [A15] Dickson 2015 [A9] Dunne 2015 [A10] Markowitz 2016 [A7]		Jamal 2013 [A56] Niccolai 2013 [A57] Hariri 2015 [A49, A55]

Abbreviations: HPV, human papillomavirus vaccine; y, years.

^a Publications may appear in >1 column if the study addresses >1 outcome. Please see Supplementary Table 2 in Supplementary Appendix II for detailed citations.

^b National HPV Vaccination Program Register. Preliminary estimates of HPV vaccination coverage for males—school-based program, first year of program delivery (2013). Available at: http://www.hpvregister.org.au/research/coverage-data/preliminary-estimates-male-hpv-coverage-2013. Accessed 27 April 2015.

^c Although included here in the original literature search, this citation did not actually provide data relevant to HPV infection.